Form D · Pharmaceuticals

Auspex Pharmaceuticals, Inc.

La Jolla, CA · CIK 0001454189

Offering snapshot reported Sep 6, 2013 · SEC filing

Reported sold
$28M
Offering amount: $28M
Investors reported
9
Form D · investor count
Minimum accepted
$0
Reported outside-investor minimum
First sale
Oct 31, 2012
As reported in this filing

Fundraising history

Reported sold
Reported amount sold by Form D filing date$0$14M$28MNov 14, 2012: $17,492,739.00Nov 14, 2012Sep 6, 2013: $27,992,742.00Sep 6, 2013

Dates are filing dates, not cash receipt dates. Decreases are reported revisions, not evidence of withdrawals. Separate offering histories are not added together.

What changed?

Latest filing versus its linked predecessor, where available.

  • Reported sold$17,492,739 → $27,992,742
  • Reported investors8 → 9

Filing history

Scroll to see all columns →

FiledFiling typeReported soldChange vs linked filingInvestorsSource
Sep 6, 2013Amendment$27,992,742$10,500,003vs Nov 14, 20129SEC filing
Nov 14, 2012Initial$17,492,739No comparison8SEC filing
Jul 31, 2012Initial$1,500,000No comparison5SEC filing
Jan 11, 2012Initial$3,000,000No comparison7SEC filing
Jul 30, 2010Initial$13,825,000No comparison5SEC filing
Jul 16, 2010Initial$11,999,999No comparison8SEC filing
Feb 26, 2010Initial$2,000,000No comparison6SEC filing
Oct 22, 2009Initial$2,000,000No comparison5SEC filing
Aug 3, 2009Initial$3,000,000No comparison7SEC filing
Jan 21, 2009PaperNot reportedNo comparisonNot reportedSEC filing

Offering details

Securities
Equity
Exemptions
06
Duration over one year
No
Business combination
No
Sales commissions
$0
Finders' fees
$0
Form D file number
021-186938

Source: Form D, filed Sep 6, 2013. Minimum accepted may differ from a standard advertised minimum.

Fund connections

No confirmed ADV fund connection is available for this issuer.

People & organizations

Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.

People and organizations reported in Form D filings
NameReported role
Gaurav Aggarwal Director
David Collier Director
Rod Ferguson Director
Lawrence C. Fritz Director, Executive
Thomas Gant Director, Executive
R. Gary Gilmore Executive
Michael Grey Director, Executive
Ron Newbold Executive
Sam Sachs Director
Samuel Saks Director
Sep Sarshar Director
Sepehr Sarshar Director
Pratik Shah Director, Executive
Sep Sharshar Director
Andreas Sommer Executive
Andreas Sommers Executive
David. A. Stamler Executive
David Stamler Executive

Issuer details

Industry: Pharmaceuticals (See others in industry)

Address:
3366 N. Torrey Pines Court Suite 225
La Jolla, CA, 92037